Impact Factor
4.49
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.62
4,759 total citations
h5-index
64
h5 depth signal
Cited share
92.2%
708 of 768
Total citations
4,759
Citation footprint
Metric signal
7.49
External metric anchor
Self-citation
2.0%
93 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
1,226
United States
846
United Kingdom
390
Germany
343
Italy
218
Citing Fields of Research
Allergies
1,114
Respiratory Support
1,020
Lung Cancer
623
Immunology
605
Auto-Inflammatory Disorders
561
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,444
Articles tracked across the journal lifetime
Indexed publication set
768
708 cited publications
Last 12 months
570
47.5 publications/month
Open access share
100.0%
570 OA publications in the last year
Leading citing country
China
1,226 citing publications
Leading citing field
Allergies
1,114 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 2000-
v1n1,2000-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Respiratory Support
Allergies
Lung Cancer
Immunology
Auto-Inflammatory Disorders
Broad Categories
Pulmonary Medicine
Allergies
Auto-Inflammatory Disorders
Respiratory Support
Cardiology
Lung Cancer
Cystic Fibrosis
MeSH Descriptors
Respiration
Respiratory Physiological Phenomena
Respiratory System
Respiratory Tract Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1186/s12931-026-03963-1
Open DOI
Single-cell transcriptomics unveils alveolar microenvironment remodeling in sepsis-induced ARDS
02
03
DOI 10.1186/s12931-026-03956-0
Open DOI
Dihydroartemisinin alleviates allergic airway inflammation by suppressing the PI3K-AKT signaling axis: integrated network pharmacology and experimental validation
Background: Allergic asthma is a heterogeneous inflammatory airway disorder driven by dysregulated immune responses and epithelial–immune crosstalk. Dihydroartemisinin (DHA), an active derivative of artemisinin, exhibits broad anti-infla...
04
05
DOI 10.1186/s12931-026-03916-8
Open DOI
E2F2 confers cisplatin resistance in lung squamous cell carcinoma via HUWE1/H2AX-mediated DNA damage repair
06
DOI 10.1186/s12931-026-03957-z
Open DOI
Safety and diagnostic yield of transbronchial lung cryobiopsy in patients with interstitial lung disease and severe pulmonary function impairment
Background: Transbronchial lung cryobiopsy (TBLC) has become an established diagnostic modality in interstitial lung disease (ILD). However, current guidelines frequently exclude patients with severely impaired lung function due to safet...
07
DOI 10.1186/s12931-026-03958-y
Open DOI
Pleural infection: from bench to bedside
08
09
DOI 10.1186/s12931-026-03917-7
Open DOI
CISD1 suppresses COPD inflammation by recruiting ubiquitinated STING and altering macrophage metabolism
10
DOI 10.1186/s12931-026-03933-7
Open DOI
Improvement in peripheral airway function after a 12-week exercise intervention in COPD
Background: Exercise is a cornerstone of chronic obstructive pulmonary disease (COPD) management and improves quality of life, exercise capacity, exacerbation frequency and survival. However, the physiological mechanisms underlying these...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with Vol. 2, no. 6 (2001).
Vol. 1 (2000) complete in 3 issues.
Supplements accompany some vols.
Also issued online.